Guzzo the Contrarian

While being a favorite of many investors throughout the 80’s and 90’s, I’ve never been much of a fan of Pfizer’s (PFE) stock as I thought that it was overvalued for a long time. But now it’s trading not only around it’s 52-week low, it’s trading around it’s 10-year low.
At what point does PFE become [...]